News
MediPrint™ Ophthalmics Announces New Corporate Branding and New Website
Plus, Company Spotlights its Successful First-in-human Clinical Study Results at Premier Eye Care and Investor Conferences SAN DIEGO, CA, USA (Business Wire, June 8th, 2021) – Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight,
MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
First-in-human Trial with Novel Glaucoma Treatment Confirmed Favorable Safety Profile and Signaled Efficacy SAN DIEGO, CA, USA (March 16th, 2021) – Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces the successful completion of the first
Leo Lens Pharma Achieves Two Significant Milestones – FDA IND Submission and Seed Round Fundraising Success
IND Paves the Way to Phase 2a Clinical Study and Seed Round Lead Advances Company’s Efforts for Its Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire, November 12th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based
Leo Lens Pharma Expands Its Scientific Advisory Board
External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion